DK3662925T3 - Sammensætning, der omfatter fsh, til behandling af infertilitet - Google Patents

Sammensætning, der omfatter fsh, til behandling af infertilitet Download PDF

Info

Publication number
DK3662925T3
DK3662925T3 DK20150379.4T DK20150379T DK3662925T3 DK 3662925 T3 DK3662925 T3 DK 3662925T3 DK 20150379 T DK20150379 T DK 20150379T DK 3662925 T3 DK3662925 T3 DK 3662925T3
Authority
DK
Denmark
Prior art keywords
infertility
treatment
composition including
including fsh
fsh
Prior art date
Application number
DK20150379.4T
Other languages
English (en)
Inventor
Saez Joan-Carles Arce
Lisbeth Helmgaard
Bjarke Mirner Klein
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK3662925T3 publication Critical patent/DK3662925T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK20150379.4T 2015-04-17 2016-04-15 Sammensætning, der omfatter fsh, til behandling af infertilitet DK3662925T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15164043 2015-04-17
EP16719315.0A EP3283097B1 (en) 2015-04-17 2016-04-15 Fsh for treatment of infertility

Publications (1)

Publication Number Publication Date
DK3662925T3 true DK3662925T3 (da) 2021-06-28

Family

ID=52997893

Family Applications (2)

Application Number Title Priority Date Filing Date
DK20150379.4T DK3662925T3 (da) 2015-04-17 2016-04-15 Sammensætning, der omfatter fsh, til behandling af infertilitet
DK16719315.0T DK3283097T3 (da) 2015-04-17 2016-04-15 Fsh til behandling af infertilitet

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK16719315.0T DK3283097T3 (da) 2015-04-17 2016-04-15 Fsh til behandling af infertilitet

Country Status (17)

Country Link
US (3) US10660938B2 (da)
EP (2) EP3662925B1 (da)
JP (2) JP7079094B2 (da)
KR (2) KR20170137041A (da)
CN (1) CN107405385A (da)
AU (1) AU2016247498B2 (da)
CA (1) CA2975444A1 (da)
DK (2) DK3662925T3 (da)
ES (2) ES2879838T3 (da)
HU (2) HUE054300T2 (da)
MA (1) MA46548B1 (da)
MX (1) MX2017010883A (da)
PL (2) PL3283097T3 (da)
PT (2) PT3662925T (da)
RU (1) RU2704252C2 (da)
SI (2) SI3662925T1 (da)
WO (1) WO2016166288A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3237608B1 (en) * 2014-12-22 2019-10-09 F. Hoffmann-La Roche AG Cmp-dependent sialidase activity
SI3662925T1 (sl) 2015-04-17 2021-08-31 Ferring B.V. Sestavek, ki vsebuje FSH za zdravljenje neplodnosti
MA50034B1 (fr) * 2017-09-01 2022-02-28 Ferring Bv Composition de stimulation ovarienne contrôlée
JP2021522268A (ja) * 2018-04-30 2021-08-30 フェリング ベスローテン フェンノートシャップ 制御された卵巣刺激のための組成物
CN112638406B (zh) 2018-06-22 2025-04-22 科优基因公司 白介素-2变体及其使用方法
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
TW202237173A (zh) * 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
EP4504236A1 (en) * 2022-04-01 2025-02-12 Ferring B.V. Mixed protocol for treatment of infertility
CN115019932B (zh) * 2022-07-26 2024-02-27 北京大学第三医院（北京大学第三临床医学院） 预测cos周期给予外源性卵泡刺激素药物剂量的系统及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228973B (de) * 1961-05-13 1966-11-17 Skf Kugellagerfabriken Gmbh Streckwerk fuer Spinnereimaschinen
US8173592B1 (en) 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
SI3662925T1 (sl) 2015-04-17 2021-08-31 Ferring B.V. Sestavek, ki vsebuje FSH za zdravljenje neplodnosti

Also Published As

Publication number Publication date
KR20240073153A (ko) 2024-05-24
JP7079094B2 (ja) 2022-06-01
EP3283097A1 (en) 2018-02-21
US20200353053A1 (en) 2020-11-12
AU2016247498B2 (en) 2021-06-03
EP3283097B1 (en) 2020-02-12
US10660938B2 (en) 2020-05-26
CN107405385A (zh) 2017-11-28
JP7161511B2 (ja) 2022-10-26
DK3283097T3 (da) 2020-04-20
PL3662925T3 (pl) 2021-10-25
JP2021020915A (ja) 2021-02-18
US11439686B2 (en) 2022-09-13
PT3662925T (pt) 2021-07-01
WO2016166288A1 (en) 2016-10-20
JP2018513161A (ja) 2018-05-24
ES2879838T3 (es) 2021-11-23
US20230139407A1 (en) 2023-05-04
MX2017010883A (es) 2017-12-07
RU2017128296A (ru) 2019-05-17
ES2784625T3 (es) 2020-09-29
PL3283097T3 (pl) 2020-10-19
HUE048757T2 (hu) 2020-08-28
US20180125942A1 (en) 2018-05-10
KR20170137041A (ko) 2017-12-12
PT3283097T (pt) 2020-04-06
HUE054300T2 (hu) 2021-08-30
EP3662925A1 (en) 2020-06-10
AU2016247498A1 (en) 2017-08-17
MA46548A (fr) 2018-02-21
EP3662925B1 (en) 2021-04-07
CA2975444A1 (en) 2016-10-20
RU2704252C2 (ru) 2019-10-25
MA46548B1 (fr) 2020-03-31
SI3662925T1 (sl) 2021-08-31
RU2017128296A3 (da) 2019-06-25
SI3283097T1 (sl) 2020-06-30

Similar Documents

Publication Publication Date Title
DK3286311T3 (da) Fremgangsmåde til behandling af maligniteter
DK3322722T3 (da) Midler, anvendelser og fremgangsmåder til behandling af synukleinopati
DK3072835T3 (da) Fremgangsmåde til fremføring
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3256853T3 (da) Forudsigelse af t-celleepitoper, der er egnede til vaccination
DK3580211T3 (da) 2-heteroaryl-3-oxo-2,3-dihydropyridazin-4-carboxamider til behandling af cancer
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3466432T3 (da) Fremgangsmåder til behandling af pulmonale non-tuberkuløse mykobakterielle infektioner
HUE054784T2 (hu) 5-klór-2-difluor-metoxifenil-pirazolopirimidin vegyületek, amelyek JAK-gátlók
DK3294700T3 (da) Fremgangsmåde til fremstilling af limonen-4-ol
DK3662925T3 (da) Sammensætning, der omfatter fsh, til behandling af infertilitet
DK3204386T3 (da) Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed
DK3524255T3 (da) Sammensætning til behandling af acne
DK3374359T3 (da) Dihydroimidazopyrazinonderivater, der er nyttige ved behandling af cancer
DK3186244T3 (da) Dioxolananaloger af uridin til behandling af cancer
DK3529233T3 (da) Fremgangsmåde til fremstilling af 3-alkylsulfanyl-2-chlor-n-(1-alkyl-1h-tetrazol-5-yl)-4-trifluoromethyl-benzamider
DK3265087T3 (da) Fremgangsmåde til behandling med tradipitant
DK3359522T3 (da) Proces til fremstilling af N-Boc-bifenylalaninol
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3393468T3 (da) Fremgangsmåder til behandling af en immundefektsygdom
DK3261661T3 (da) Menotropin til behandling af infertilitet
DK3262023T3 (da) Fremgangsmåde til fremstillingen af diener
DK3390407T3 (da) Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
DK3302573T3 (da) Sammensætning til behandlingen af hjernelæsioner